Zydelig

Idelalisib is an oral medication prescribed for certain blood cancers. It belongs to the class of kinase inhibitors and is used to manage chronic lymphocytic leukemia and follicular lymphoma. This page provides neutral, factual details about its uses, effects, and safety.

Idelalisib is primarily used to treat chronic lymphocytic leukemia and follicular lymphoma in adults when other treatments have not been effective. It works by targeting specific proteins in cancer cells, helping to slow or stop their growth. Patients often ask, 'what is idelalisib used for' when exploring treatment options for these conditions.

Idelalisib may help reduce symptoms associated with certain blood cancers, such as fatigue or swelling in lymph nodes. Some users report improved energy levels or reduced discomfort over time. Individual responses vary, and effects should be monitored by a healthcare provider.

Idelalisib should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including liver conditions or infections, before starting treatment. Regular blood tests may be required to monitor for side effects.

Idelalisib can interact with other medications, including some antibiotics, antifungals, and herbal supplements. Combining it with certain drugs may increase the risk of side effects or reduce effectiveness. Always inform your doctor about all medications you are taking.